Biontech Co-founder Sahin does not expect a return to normal until the

Biontech Co-founder Sahin does not expect a return to normal until the end of 2021

The vaccine developed by Biontech is one of the beacons of hope in the fight against the corona pandemic – but the vaccine has not yet had any effect on the upcoming winter. Co-founder Sahin does not expect a return to normal until the end of 2021.

The co-founder of the vaccine developer Biontech, Ugur Sahin, expects a return to normality by winter 2021. But it is “essential” to achieve a high vaccination rate against the coronavirus before autumn, and he told the British television broadcaster BBC. But he is optimistic that this could succeed.

The vaccine developed by Biontech and the US pharmaceutical giant Pfizer is one of the hopes in the fight against the pandemic. Company boss Sahin announced that the developed vaccine would already be available from the end of this year or early 2021 – “if everything goes well,” he added. However, he spoke of a “harsh winter” and pointed out that vaccines developed soon would not significantly impact the current cold season. Biontech’s goal, however, is to deliver more than 300 million cans by April: “That could have an effect,” said Sahin.

The German government supported Biontech.

The Mainz-based company Biontech and its US partner Pfizer made headlines last week with the announcement that the current clinical trial had found their vaccine candidate’s effectiveness of more than 90 percent. Biontech was founded in 2008 by Sahin, his wife Özlem Türeci, and the Austrian cancer researcher Christoph Huber.

Two years ago, the company signed a collaboration agreement with Pfizer that was expanded to include a vaccine search in March of this year because of the coronavirus pandemic. Biontech supported by the German government, amounting to 375 million euros for the research.

However, shortly after the announcement, according to a survey, vaccination readiness has hardly changed in Germany.

Biontech Co-founder Sahin does not expect a return to normal until the end of 2021